Submucosal Plexus (Meissner) Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The submucosal plexus, also known as Meissner's plexus, is a major component of the enteric nervous system (ENS) located in the submucosa of the gastrointestinal tract. Unlike the myenteric plexus (Auerbach's plexus) which primarily controls motility, the submucosal plexus regulates intestinal secretion, blood flow, and mucosal integrity. This plexus is increasingly recognized for its role in the gut-brain axis and its involvement in neurodegenerative diseases, particularly Parkinson's disease.
The submucosal plexus is strategically positioned within the gastrointestinal wall:
- Submucosa Layer: Located just beneath the mucosa
- Distribution: Most dense in the small intestine and colon
- Organization: Ganglionated network with interconnected neurons
| Component |
Description |
| Ganglia |
Clusters of neuronal cell bodies (20-30 neurons per ganglion) |
| Interneurons |
Connect ganglia within the plexus |
| Fiber Plexuses |
Secondary networks for signal distribution |
| Glial Cells |
Support and protect neurons |
| Feature |
Submucosal Plexus |
Myenteric Plexus |
| Location |
Submucosa |
Between muscle layers |
| Primary Function |
Secretion, blood flow |
Motility |
| Neuron Density |
Lower |
Higher |
| Ganglia Size |
Smaller |
Larger |
The majority of submucosal neurons are secretomotor neurons:
- Cholinergic Secretomotor: Release acetylcholine to stimulate secretion
- VIPergic Secretomotor: Vasoactive intestinal peptide for secretion
- Combined Phenotypes: Some neurons release both ACh and VIP
Control intestinal blood flow:
- Nitrergic: Nitric oxide-mediated vasodilation
- VIPergic: Vasoactive intestinal peptide effects
- Purinergic: ATP-mediated signaling
Detect mucosal and luminal changes:
- Mucosal Chemoreceptors: Detect nutrient content
- Mechanoreceptors: Sense stretch and tension
- Osmoreceptors: Monitor osmotic changes
Coordinate local circuits:
- Ascending Interneurons: Propagate signals orally
- Descending Interneurons: Anal signal propagation
The submucosal plexus controls all secretory processes:
-
Chloride Secretion
- Activates CFTR chloride channels
- Water follows osmotically
- Results in luminal fluid secretion
-
Mucus Release
- Goblet cell stimulation
- Protective barrier enhancement
- Lubrication for passage
-
Electrolyte Transport
- Sodium absorption
- Potassium secretion
- Bicarbonate exchange
Maintains intestinal perfusion:
- Functional Hyperemia: Increases blood flow during digestion
- Protective Vasoconstriction: Reduces flow during stress
- Mucosal Oxygenation: Ensures adequate oxygen supply
Critical barrier function:
- Mucus Production: Physical barrier to pathogens
- Antimicrobial Peptide Release: Innate immune defense
- Barrier Tightness: Maintains mucosal integrity
The two plexuses work together:
- Motility-Secretion Coupling: Coordinated peristalsis with secretion
- Local Reflexes: Independent of central nervous system
- Neural Circuits: Complex integration for gut function
-
Vagal Afferents
- Submucosal neurons → vagus nerve → brainstem
- Transmit secretory and mucosal information
-
Spinal Afferents
- Via dorsal root ganglia
- Sympathetic pathways
-
Enteric Neural Circuits
- Local processing
- Integration with myenteric plexus
Shared neurochemistry with central nervous system:
- Acetylcholine: Primary excitatory transmitter
- Vasoactive Intestinal Peptide: Key secretory regulator
- Nitric Oxide: Inhibitory/vascular effects
- Serotonin: Motility and secretion modulation
- Dopamine: Present in ENS, altered in PD
α-Synuclein Pathology:
- Lewy bodies found in submucosal neurons
- May precede brain involvement by years
- Detectable in rectal biopsies
- Potential early biomarker
GI Dysfunction:
- Constipation (most common early symptom)
- Secretory abnormalities
- Altered mucosal function
- Small intestinal bacterial overgrowth
Mechanisms:
- Misfolded α-synuclein propagation
- Impaired autophagy
- Mitochondrial dysfunction
- Neuroinflammation
Diagnostic Implications:
- Rectal biopsy for α-synuclein
- Correlation with disease duration
- Potential for early diagnosis
Cholinergic Dysfunction:
- ENS cholinergic neurons affected
- Contributes to GI dysmotility
- Altered secretion patterns
Autonomic Involvement:
- Vagal degeneration
- Submucosal neuronal loss
- Autonomic regulation changes
Gut-Brain Communication:
- Cholinergic anti-inflammatory pathway
- Altered in AD
- May affect disease progression
While not neurodegenerative, IBD shares mechanisms:
- Enteric nervous system inflammation
- α-Synuclein abnormalities
- May model neurodegenerative processes
| Marker |
Expression |
Use |
| HuC/D |
All enteric neurons |
General neuronal marker |
| PGP9.5 |
Neuronal cytoplasm |
Pan-neuronal |
| S100β |
Glial cells |
Enteric glia |
| nNOS |
Inhibitory neurons |
Nitric oxide producers |
| ChAT |
Cholinergic neurons |
Excitatory transmission |
- VIP: Vasointestinal peptide
- CGRP: Calcitonin gene-related peptide
- Substance P: Tachykinin
- Somatostatin: Inhibitory peptide
- Rectal Biopsy: α-Synuclein detection
- Colonic Biopsy: Neuronal morphology
- Small Intestinal Biopsy: Research applications
- Secretory Function Tests: Electrolyte measurement
- Blood Flow Studies: Laser Doppler
- Manometry: Pressure measurements
- Prokinetic Agents: Enhance propulsion
- Secretory Modulators: Regulate fluid balance
- Anti-inflammatory Agents: Reduce neuroinflammation
- α-Synuclein Targeting: Immunotherapies
- Stem Cell-Based Treatments: Neuronal replacement
- Gene Therapy: Restore function
- Microbiome Modulation: Alter gut-brain signaling
- Whole-Mount Preparations: Network visualization
- Intracellular Recording: Electrophysiology
- Calcium Imaging: Activity mapping
- Optogenetics: Circuit manipulation
- Rodent ENS studies
- Transgenic α-synuclein models
- Parkinson's disease models
Submucosal Plexus (Meissner) Neurons plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Submucosal Plexus (Meissner) Neurons has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
-
Furness JB. The enteric nervous system: normal functions and enteric neuropathies. Gastroenterology (2008)
-
Wood JD. Enteric nervous system: the brain-in-the-gut. J Neurogastroenterol Motil (2013)
-
Braak H, de Vos RAI, Bohl J, Del Tredici K. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett (2006)
-
Sharrad DF, de Vries E, Brookes SJ. The expression of calcitonin gene-related peptide by enteric neurons in the mouse colon. J Comp Neurol (2013)
-
Bornstein JC, Furness JB, Kunze WA. Electrophysiological characterization of myenteric neurons: how do classification schemes relate? J Auton Nerv Syst (1994)
-
Costa M, Brookes SJ, Hennig G. Anatomy and physiology of the enteric nervous system. Gut (2000)
-
Wakabayashi K, Takahashi H, Takeda S, Ohama E, Ikuta F. Parkinson's disease: the presence of Lewy bodies in Auerbach's and Meissner's plexuses. Acta Neuropathol (1988)
-
Gershon MD. The enteric nervous system: a second brain. Hosp Pract (2013)